Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Polypid Ltd - SIC # 2833 - MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS
Ticker
Exchange
SIC #
Website
Latest Ticker
PYPD
Nasdaq
2833
https://www.polypid.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Polypid Ltd
PolyPid to Participate in Barclays 26th Annual Global Healthcare Conference
- Feb 28th, 2024 12:00 pm
PolyPid Ltd. (PYPD) Upgraded to Buy: What Does It Mean for the Stock?
- Feb 19th, 2024 5:00 pm
PolyPid Ltd. (NASDAQ:PYPD) Q4 2023 Earnings Call Transcript
- Feb 15th, 2024 2:41 pm
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
- Feb 14th, 2024 12:00 pm
PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial
- Feb 12th, 2024 12:00 pm
PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on February 14, 2024
- Jan 31st, 2024 12:00 pm
PolyPid Announces Private Placement for $16 Million in Gross Proceeds
- Jan 4th, 2024 9:32 pm
PolyPid Ltd. (NASDAQ:PYPD) Q3 2023 Earnings Call Transcript
- Nov 12th, 2023 3:40 pm
PolyPid Provides Corporate Update and Reports Third Quarter 2023 Financial Results
- Nov 8th, 2023 12:00 pm
PolyPid Announces the Addition of Dr. Nurit Tweezer-Zaks to its Board of Directors
- Nov 7th, 2023 12:00 pm
PolyPid to Report Third Quarter 2023 Financial Results and Operational Highlights on November 8, 2023
- Nov 1st, 2023 11:00 am
PolyPid Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
- Oct 11th, 2023 11:00 am
PolyPid Announces Presentation at the American College of Surgeons Clinical Congress 2023
- Oct 9th, 2023 11:00 am
PolyPid Announces Publication of Preclinical Data Further Supporting the Good Safety Profile of D-PLEX₁₀₀ and PLEX Technology Platform
- Oct 4th, 2023 11:00 am
PolyPid to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
- Sep 22nd, 2023 11:00 am
PolyPid Announces Successful Commercial Good Manufacturing Practice (GMP) Audit by Israeli Ministry of Health
- Sep 21st, 2023 11:34 am
PolyPid Announces Reverse Share Split
- Sep 20th, 2023 1:15 pm
PolyPid Announces Successful Completion of Manufacturing Process Validation for D-PLEX₁₀₀
- Sep 19th, 2023 11:00 am
PolyPid Provides Corporate Update and Reports Second Quarter 2023 Financial Results
- Aug 9th, 2023 11:00 am
PolyPid to Report Second Quarter 2023 Financial Results and Operational Highlights on August 9, 2023
- Jul 26th, 2023 11:00 am
Scroll